Raw264.7 cell directionally polarized M2 macrophage combined reagent as well as preparation method and application thereof
By providing a combination reagent including induction reagent, dedicated culture medium and digestive medium, the problem of complex operation and low purity in the Raw264.7 cell polarized M2 macrophage model is solved, and efficient and simplified M2 macrophage is achieved. Cell induction, suitable for disease treatment research.
Patent Information
- Application Number
- CN202410968784.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-19
- Publication Date
- 2024-11-15
AI Technical Summary
The prior art is complex in the Raw264.7 cell polarized M2 macrophage model, with low success rate and limited purity, which limits the progress of M2 macrophage-related research, especially in the treatment of disease. .
Provide a ready-to-use Raw264.7 cell-directed polarized M2 macrophage combination reagent, including induction reagents, special medium and digestive medium, which can reach 90% in 24 hours through specific preparation steps and component ratios. M2 macrophages have good freezing and thermal stability, which simplified experimental operations.
It has achieved efficient induction of M2 macrophages in a short period of time (24 hours), improved cell purity and experimental success rate, simplified the operation process, was suitable for promotion and use, and maintained the frozen storage and thermal stability of the inducer.
Smart Images

Figure CN118956750A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of biomedicine, and in particular relates to a Raw264.7 cell-directionally polarized M2 macrophage combination reagent, and a preparation method and application thereof. Background Art
[0002] Macrophages are a heterogeneous group of bone marrow cells in the innate immune system. They play an extremely important role in the body's defense against pathogenic microbial infection, tumors, allergic diseases, metabolic diseases, tissue damage and repair. Among them, M2 macrophages mainly play the role of anti-inflammatory, anti-parasitic infection and tissue repair. They play an important role in anti-parasitic immune response, allergic reaction, tissue damage repair and tissue reconstruction.
[0003] M2 macrophages are induced by IL-4 or IL-13, with increased expression of CD206 and arginase, enhanced endocytosis ability, secretion of anti-inflammatory cytokines such as IL-10 and TGF-β, and promotion of Th2 cell differentiation, exerting immune regulation and tissue repair functions. Their antigen presentation ability is relatively weak, and they play an important role in parasite immune response, allergic reaction, wound healing and tissue reconstruction.
[0004] The marker molecules, inducing factors, and key signaling molecules for plasticity reversal of M2 macrophages during the occurrence and development of diseases are not completely clear. Most of the previous studies were conducted on polarized M2 macrophage models of cell lines such as Raw264.7 cells, and some new and effective solutions were proposed for the treatment of related diseases. Currently, the commonly used solutions for the polarized M2 cell model of Raw264.7 cells include IL-4 and IL-13 or LPS or IL-1, etc., but the experimental operation is complicated, the experimental success rate is low, and the purity of the obtained M2 macrophages is limited, which greatly limits the relevant research on M2 macrophages. Therefore, it is urgent to improve the existing technology and provide a short-term and high-induction rate method to solve the above problems. Summary of the invention
[0005] In view of this, the present invention provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and a preparation method and application thereof. The combination reagent of the present invention can be used to polarize Raw264.7 cells into M2 macrophages, and the purity can reach 90% in 24 hours.
[0006] In order to achieve the above object, the present invention adopts the following technical solutions:
[0007] A combination reagent for directing the polarization of Raw264.7 cells into M2 macrophages, the combination reagent comprising an inducing agent;
[0008] The induction reagent includes the following components: NaCl 8-10g / L, KCl 0.5-1.1g / L, KH2PO4 0.2-0.5g / L, Na2HPO4 0.5-1.4g / L, IL-4 0.1-1g / L, IL-13 0.1-1g / L, L-arginine 0.1-0.5g / L, and at least one of BSA 0.1-3g / L, trehalose 10-50g / L, and glycerol 0.1-1%.
[0009] In some specific embodiments, preferably, the induction reagent includes the following components: NaCl 8.6 g / L, KCl 0.8 g / L, KH2PO4 0.3 g / L, Na2HPO4 1.1 g / L, IL-4 0.65 g / L, IL-13 0.4 g / L, L-arginine 0.25 g / L, and at least one of BSA 1.2 g / L, trehalose 15 g / L, and glycerol 0.8%.
[0010] Furthermore, the combination reagent also includes a special culture medium, which includes the following components: 5-20% fetal bovine serum, 0.1-1 g / L 2-mercaptoethanol, 0.5-2 g / L L-alaninamide, 0.5-2 g / L L-glutamine, and RPMI1640 basal culture medium.
[0011] Furthermore, the combination reagent also includes a digestion medium, which includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH2PO4 0.2-0.5 g / L, Na2HPO4 0.5-1.4 g / L, trypsin 0.2-2 g / L, and EDTA-2Na 0.1-1 g / L.
[0012] The preparation method of the above-mentioned combination reagent, the preparation steps of the induction reagent in the combination reagent are as follows: first take NaCl, KCl, KH2PO4, Na2HPO4, dissolve them in sterilized ultrapure water, stir to dissolve, then add at least one of BSA, glycerol, and trehalose, stir to dissolve, then adjust the pH to 7.2-7.4, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain a buffer solution; add IL-4, IL-13, and L-arginine to the above-mentioned buffer solution, gently blow and mix, and store at -20°C away from light to obtain the induction reagent.
[0013] Furthermore, the preparation steps of the special culture medium in the combination reagent are as follows: take 2-mercaptoethanol, L-alanineamide, and L-glutamine, add RPMI1640 basal culture medium, stir to dissolve in the dark, then add fetal bovine serum, mix well, and then adjust the pH to 7.2-7.4, filter through a 0.22μm filter membrane for sterilization, and store at 4°C in the dark to obtain a special culture medium.
[0014] Furthermore, the preparation steps of the digestion medium in the combination reagent are as follows: take NaCl, KCl, KH2PO4, and Na2HPO4 and dissolve them in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, and then adjust the pH to 7.2-7.4, and finally add trypsin to dissolve, make up to volume, filter and sterilize through a 0.22μm filter membrane, and store at 4°C to obtain the digestion medium.
[0015] The method for obtaining M2 macrophages by using the above-mentioned combination reagent to polarize Raw264.7 comprises the following steps:
[0016] S1, pipette Raw264.7 cells, centrifuge, discard the supernatant, resuspend the cell pellet with a special culture medium, count the cells, adjust the cell density, and inoculate in a cell culture dish;
[0017] S2, add induction reagent, transfer to CO2 incubator at 37℃ and culture for 22-26h, remove supernatant, add special culture medium, shake to wash, and discard supernatant;
[0018] S3, add digestion medium, shake to soak, and incubate in a CO2 incubator at 37°C for 2 to 5 minutes, and digestion is complete;
[0019] S4. Collect the digested cells by blowing the cell dish, centrifuge, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M2 macrophages.
[0020] Furthermore, in step S1, the cell density is 1 to 5×10 5 / mL, and the centrifugation conditions were all 140-160g for 2-4min; the amount of induction reagent added in step S2 was 1 μL of induction reagent added to 1mL of cell suspension; the centrifugation conditions in S3 were all 140-160g for 2-4min.
[0021] A ready-to-use Raw264.7 cell polarization M2 macrophage kit, the kit comprising the above-mentioned combined reagent.
[0022] Compared with the prior art, the present invention has the following beneficial effects:
[0023] The ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent provided by the present invention can achieve an induction rate of 92% in a short time (only 24 hours), solving the problems of high difficulty and low purity of Raw264.7 cell polarization M2; the inducer has good freezing stability (10 times of repeated freezing and thawing at -20°C still does not affect the induction effect) and good thermal stability (after 14 days of thermal acceleration treatment at 37°C, the induction effect is still not affected); in addition, the overall reagent preparation, induction process, etc. are simple to operate, and are suitable for popularization and use. BRIEF DESCRIPTION OF THE DRAWINGS
[0024] Figure 1 This is a microscope picture of the reagent and blank control group after induction in Example 1 of the present invention.
[0025] Figure 2 This is a flow cytometry test result diagram of the reagent and blank control group after induction in Example 1 of the present invention.
[0026] Figure 3 These are microscope images of the reagents and the blank control group after induction in Example 1 and Comparative Example 1 of the present invention.
[0027] Figure 4 This is a flow cytometry test result diagram of the reagents and the blank control group after induction in Example 1 and Comparative Example 1 of the present invention.
[0028] Figure 5 These are microscope images of the reagents and the blank control group after induction in Examples 1-3 and Comparative Example 2 of the present invention.
[0029] Figure 6 These are microscope images of the reagents after repeated freezing and thawing in Example 4 of the present invention and Comparative Example 3 and the blank control group after induction.
[0030] Figure 7 The flow cytometer detection results of the reagents in Example 4 and Comparative Example 3 of the present invention after repeated freezing and thawing and the blank control group after induction are shown.
[0031] Figure 8 These are microscope images of the reagents after heating treatment in Example 4 of the present invention and Comparative Example 3 and the blank control group after induction.
[0032] Fig. 9 It is a flow cytometry detection result diagram of the reagents after heating treatment in Example 4 of the present invention and Comparative Example 3 and the blank control group after induction. DETAILED DESCRIPTION
[0033] The present invention is further described in detail below in conjunction with specific embodiments so that those skilled in the art can understand the present invention more clearly.
[0034] Sources and physical and chemical parameters of key test materials:
[0035] Interleukin-4 (IL-4) and interleukin-13 (IL-13) were purchased from ACRO Biosystems.
[0036] Trypsin and RPMI1640 basal culture medium were purchased from Procell Life Science Co., Ltd.
[0037] Example 1
[0038] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. The combination reagent includes an induction reagent, a special culture medium, and a digestion culture medium. The specific components of each reagent are shown in Table 1 below.
[0039] Table 1 Details of the specific components of induction reagents, special culture medium, and digestion medium
[0040]
[0041]
[0042] Prepare each reagent according to the component details in Table 1, where the preparation steps of the induction reagent are as follows: first take NaCl, KCl, KH2PO4, Na2HPO4, dissolve them in sterilized ultrapure water, stir to dissolve, then add BSA, trehalose, and glycerol, stir to dissolve, then adjust the pH to 7.2, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain a buffer solution; add IL-4, IL-13, and L-arginine to the above buffer solution, gently blow to mix, and store at -20°C away from light to obtain the induction reagent.
[0043] The steps for preparing the special culture medium are as follows: take 2-mercaptoethanol, L-alanineamide, and L-glutamine, add them to RPMI1640 basal culture medium, stir to dissolve in the dark, then add fetal bovine serum, mix well, then adjust the pH to 7.2, filter through a 0.22 μm filter membrane to sterilize, and store at 4°C in the dark to obtain the special culture medium.
[0044] The steps for preparing the digestion medium are as follows: take NaCl, KCl, KH2PO4, and Na2HPO4, dissolve them in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, and then adjust the pH to 7.2-7.4, and finally add trypsin to dissolve, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain the digestion medium.
[0045] Furthermore, a method for polarizing Raw264.7 to obtain M2 macrophages using the above-prepared combination reagent comprises the following steps:
[0046] S1. Pipette Raw264.7 cells, centrifuge at 150 g for 3 min, discard the supernatant, resuspend the cell pellet in a special culture medium, count the cells, and adjust the cell density to 2.5 × 10 5 / mL, inoculated in cell culture dishes;
[0047] S2, add 1 μL of induction reagent to every 1 mL of cell suspension, transfer to a CO2 incubator at 37°C and culture for 24 h, observe the cell state under a microscope and take photos, remove the supernatant, add special culture medium, shake to wash, and discard the supernatant;
[0048] S3, add digestion medium, shake to soak, and incubate in a CO2 incubator at 37°C for 2 minutes, and the digestion is complete;
[0049] S4. Collect the digested cells by blowing the cell dish, centrifuge at 150g for 3 min, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M2 macrophages.
[0050] Example 2
[0051] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. Its raw materials and methods are basically the same as those in Example 1, except that: the concentrations of the components in each reagent are different. The specific component concentrations are detailed in Table 2.
[0052] Table 2 Details of the specific components of induction reagents, special culture medium, and digestion medium
[0053]
[0054]
[0055] Example 3
[0056] This embodiment provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 1, except that the concentrations of the components in each reagent are different. The specific component concentrations are detailed in Table 3.
[0057] Table 3 Details of the components of induction reagents, special culture medium, and digestion medium
[0058]
[0059]
[0060] Example 4
[0061] The present embodiment provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 1, except that: the material components in the induction reagent are different; in addition, the induction method is basically the same as the induction method in Example 1, but there are two situations, one of which is to repeatedly freeze and thaw the induction reagent 10 times before induction, and the other is to heat accelerate the induction reagent at 37°C for 14 days before induction, and the rest remain unchanged. The specific differences in the induction reagents are shown in Table 4.
[0062] Table 4 Specific induction reagents details
[0063]
[0064] Comparative Example 1
[0065] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. Its raw materials and methods are basically the same as those in Example 1, except that: the types of induction reagents are different and the corresponding induction times are different, and the rest remain unchanged. The specific induction reagents and corresponding induction times are shown in Table 5.
[0066] Table 5 Detailed list of induction reagents and corresponding induction time
[0067] category Differences in induction reagent types Induction time Comparative Example 1-1 Only IL-4 (10 ng / mL) and IL-13 (10 ng / mL) were added 24h Comparative Example 1-2 Only IL-4 (10 ng / mL) and IL-13 (10 ng / mL) were added 72h Comparative Examples 1-3 Only IL-4 (10 ng / mL) and IL-10 (10 ng / mL) were added 24h Comparative Examples 1-4 Only IL-4 (10 ng / mL) and IL-10 (10 ng / mL) were added 72h
[0068] Comparative Example 2
[0069] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. Its raw materials and methods are basically the same as those in Example 1, except that: the material components in the induction reagent are different, and the rest remain unchanged. The specific differences in the induction reagents are shown in Table 6.
[0070] Table 6 Detailed list of induction reagents and corresponding induction time
[0071]
[0072] Comparative Example 3
[0073] This comparative example provides a ready-to-use Raw264.7 cell-directed polarization M2 macrophage combination reagent and its preparation method and application. The raw materials and methods are basically the same as those in Example 4, except that BSA, trehalose and glycerol are removed from the induction reagent, and the rest remain unchanged.
[0074] Furthermore, in order to understand the induction effects of the above-mentioned embodiments and comparative examples, a test was conducted.
[0075] A blank control group (without induction reagent) was set up, and the FC receptor blocker was added to the M2 macrophage solution obtained in the above embodiments and comparative examples, and incubated at room temperature for 10 minutes; then, the M2 macrophage phenotype marker antibodies CD11b, F4 / 80, CD86, and CD206 were added, and the mixture was gently blown; then, PBS buffer was added to each group, and the cells were gently blown to mix, centrifuged at room temperature for 3 minutes at 150g, and the supernatant was discarded; finally, flow cytometry was used to analyze the proportion of CD11b+F4 / 80+CD86-CD206+ cells, which was the proportion of M2 macrophages. The test results are shown in Figure 1-9 .
[0076] Figure 1 The uninduced blank cells were round, while the M2 cells induced by directional polarization in Example 1 were long spindle-shaped with obvious pseudopodia. Figure 2 The ratio of M2 cells, i.e., CD11b+F4 / 80+CD86-CD206+ cells, induced by polarization in Example 1 is 92%. The RAW264.7 cell polarization M2 induction mixture in the figure is the combination reagent in Example 1.
[0077] Depend on Figure 3 , 4 It can be seen that compared with Comparative Example 1, whether it is long-term induction (72h) or short-term induction (24h), the induction effect of Example 1 is obviously better after changing the type of inducer; among them, the induction rate results of various inducers in Comparative Example 1 are all lower than 12%.
[0078] Depend on Figure 5 , 6 It can be seen that the induction effect of changing the content of IL-4, IL-13, and L-arginine on the basis of the inducer provided in Example 1 is very different, and the induction combination reagent in Comparative Example 2 has almost no effect on the polarization of Raw264.7 cells to M2. It shows that the inducer provided in this application needs to be added with IL-4, IL-13, and L-arginine at the same time to achieve the technical effects of short induction time and high induction rate. In the figure, mixture 1 is the combination reagent in Example 2, mixture 2 is the combination reagent in Example 1, mixture 3 is the combination reagent in Example 3, mixture 4 is the combination reagent of Comparative Example 2-1 in Comparative Example 2, and mixture 5 is the combination reagent of Comparative Example 2-2 in Comparative Example 2.
[0079] Depend on Figure 7 , 8It can be seen that compared with the blank control group, the cell inducer without BSA, trehalose and glycerol had a poor effect after freezing and thawing 10 times, and the number of induced Raw264.7 cells differentiated into M2 cells was small. When at least one of BSA, trehalose and glycerol was added, the induced cells were M2 cells with obvious pseudopodia, indicating that adding at least one of BSA, trehalose and glycerol to the mixture can effectively protect the freezing stability of the reagent and have the phenotypic characteristics of M2 macrophages CD11b+F4 / 80+CD86-CD206+.
[0080] Depend on Fig. 9 It can be seen that compared with the blank control group, the cell inducer without BSA, trehalose and glycerol had a poor effect after 14 days of heat acceleration at 37°C, and the number of induced Raw264.7 cells differentiated into M2 cells was small. When at least one of BSA, trehalose and glycerol was added, the induced cells were M2 cells with obvious pseudopodia, and flow cytometry detected the phenotypic characteristics of M2 macrophages CD11b+F4 / 80+CD86-CD206+. This shows that adding at least one of BSA, trehalose and glycerol to the mixture can effectively protect the thermal acceleration stability of the reagent.
[0081] Figure 7-9 In the figure: mixture 1 is the combination reagent in comparative example 3, mixture 2 is the combination reagent of Example 4-1 in Example 4, mixture 3 is the combination reagent of Example 4-2 in Example 4, mixture 4 is the combination reagent of Example 4-3 in Example 4, and mixture 5 is the combination reagent of Example 4-4 in Example 4.
[0082] In summary, the present invention provides a ready-to-use Raw264.7 cell directional polarization M2 combination reagent and its preparation method and application, which are simple to operate, greatly improve the accuracy of the experiment, and the purity of the M2 target cells is more than 90%, and the induction time is shortened from 72h to 24h, which solves the problems of high difficulty and low purity of Raw264.7 cell polarization M2, and provides favorable support for the subsequent research on the Raw264.7 cell-induced M2 cell model.
[0083] The specific raw materials not described in the present invention are all existing materials and can be directly purchased from the market.
[0084] The above are only preferred embodiments of the present invention and are not intended to limit the protection scope of the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention.
Claims
1. A combination of reagents for directing the polarization of Raw264.7 cells into M2 macrophages, It is characterized in that The combination of agents includes an inducing agent; The induction reagent includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH 2 PO 4 0.2~0.5g / L, Na 2 HPO 4 0.5-1.4 g / L, IL-4 0.1-1 g / L, IL-13 0.1-1 g / L, L-arginine 0.1-0.5 g / L, and at least one of BSA 0.1-3 g / L, trehalose 10-50 g / L, and glycerol 0.1-1%.
2. The combination reagent according to claim 1, It is characterized in that The induction reagent includes the following components: NaCl 8.6 g / L, KCl 0.8 g / L, KH 2 PO 4 0.3g / L, Na 2 HPO 4 1.1 g / L, IL-4 0.65 g / L, IL-13 0.4 g / L, L-arginine 0.25 g / L, and at least one of BSA 1.2 g / L, trehalose 15 g / L, and glycerol 0.8%.
3. The combination reagent according to claim 1 or 2, It is characterized in that The combination reagent also includes a special culture medium, which includes the following components: 5-20% fetal bovine serum, 0.1-1 g / L 2-mercaptoethanol, 0.5-2 g / L L-alaninamide, 0.5-2 g / L L-glutamine, and RPMI1640 basic culture medium.
4. The combination reagent according to claim 1 or 2, It is characterized in that The combined reagent also includes a digestion medium, which includes the following components: NaCl 8-10 g / L, KCl 0.5-1.1 g / L, KH 2 PO 4 0.2~0.5g / L, Na 2 HPO 4 0.5~1.4g / L, trypsin 0.2~2g / L, EDTA-2Na 0.1~1g / L.
5. A method for preparing the combined reagent according to any one of claims 1 to 4, It is characterized in that The steps for preparing the induction reagent in the combined reagent are as follows: first take NaCl, KCl, KH 2 PO 4 、Na 2 HPO 4 , dissolved in sterile ultrapure water, stirred to dissolve, then added at least one of BSA, glycerol, and trehalose, stirred to dissolve, and then adjusted the pH to 7.2-7.4, fixed volume, filtered through a 0.22 μm filter membrane for sterilization, and stored at 4°C to obtain a buffer solution; IL-4, IL-13, and L-arginine were added to the above buffer solution, gently pipetted to mix, and stored at -20°C away from light to obtain an induction reagent.
6. The preparation method according to claim 5, It is characterized in that The steps for preparing the special culture medium in the combination reagent are as follows: take 2-mercaptoethanol, L-alanine amine, and L-glutamine, add them to RPMI1640 basic culture medium, stir and dissolve in the dark, then add fetal bovine serum, mix well, then adjust the pH to 7.2-7.4, filter through a 0.22 μm filter membrane for sterilization, and store at 4° C. in the dark to obtain the special culture medium.
7. The preparation method according to claim 5, It is characterized in that The steps for preparing the digestion medium in the combined reagent are as follows: take NaCl, KCl, KH 2 PO 4 、Na 2 HPO 4 Dissolve in sterilized ultrapure water, stir to dissolve, then add EDTA-2Na, stir to dissolve, adjust the pH to 7.2-7.4, finally add trypsin to dissolve, make up to volume, filter through a 0.22μm filter membrane to sterilize, and store at 4°C to obtain the digestion medium.
8. A method for obtaining M2 macrophages by using the combination agent of any one of claims 1 to 4 through directional polarization of Raw264.7, It is characterized in that The following steps are involved: S1, pipette Raw264.7 cells, centrifuge, discard the supernatant, resuspend the cell pellet with a special culture medium, count the cells, adjust the cell density, and inoculate in a cell culture dish; S2, add induction reagent, transfer to 37℃ CO 2 Incubate in an incubator for 22 to 26 hours, remove the supernatant, add special culture medium, shake to wash, and discard the supernatant; S3. Add digestion medium, shake to infiltrate, and place at 37°C CO 2 Incubate in the incubator for 2 to 5 minutes, and the digestion is complete; S4. Collect the digested cells by blowing the cell dish, centrifuge, discard the supernatant, and resuspend the cell pellet with PBS buffer to obtain M2 macrophages.
9. The method according to claim 8, It is characterized in that The cell density in step S1 is 1 to 5×10 5 / mL, and the centrifugation conditions were all 140-160g for 2-4min; the amount of induction reagent added in step S2 was 1 μL of induction reagent added to 1mL of cell suspension; the centrifugation conditions in S3 were all 140-160g for 2-4min.
10. A ready-to-use Raw264.7 cell polarization M2 macrophage kit, It is characterized in that The kit comprises the combined reagent according to any one of claims 1 to 4.
Citation Information
Cited By
Complete medium special for Raw264.7 mouse mononuclear macrophage leukemia cells and application
CN120574782A
Raw264.7 mouse monocyte macrophage leukemia cell special complete culture medium and application
CN120574782B
